Completed PHASE4 INTERVENTIONAL 2-arm NCT03185130

Intravenous Fluids in Benign Headaches Trial (I-FiBH)

Intravenous Fluids in Benign Headaches Trial: A Randomized Single Blind Clinical Trial

Sponsor: University Medical Center of Southern Nevada

Conditions Headache

Interventions Diphenhydramine 1 mg/kg up to 50 mg IV Normal Saline 20mL/kg Normal Saline 5mL Prochlorperazine 0.15 mg/kg up to 10 mg IV

Updated 9 times since 2017 Last updated: May 9, 2024 Started: May 16, 2017 Primary completion: May 15, 2019 Completion: May 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Headache and is currently completed. University Medical Center of Southern Nevada leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Dec 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jul 2020 — Dec 2020 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

Jul 2018 — Jul 2020 [monthly]

Recruiting PHASE4
Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE4
Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jul 2017 — Aug 2017 [monthly]

Recruiting PHASE4

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Center of Southern Nevada

Data source: University Medical Center of Southern Nevada

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Las Vegas, United States